- Active not recruitingPHASE2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
The MoonStone study is looking at a new medicine called obexelimab for people with relapsing multiple sclerosis (MS). It aims to see if obexelimab can help and if it's safe. Participants will get either the new medicine or a dummy treatment, then everyone will get the new medicine.
For: Relapsing Multiple SclerosisUnited States · Austria · Belgium - Active not recruitingPHASE3
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
This study is testing a new medicine called obexelimab for IgG4-related disease. It wants to see if this medicine can stop flare-ups of the condition and if it's safe to use. Half the participants will get the new medicine and the other half will get a dummy medicine.
For: IgG4 Related DiseaseUnited States · Argentina · Canada - RecruitingPHASE2
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
This study is testing a new medicine called Obexelimab for people with lupus. It aims to see if the medicine is safe and helps improve symptoms. Participants will either receive Obexelimab or a dummy medicine for 24 weeks, followed by a check-up period.
For: Systemic Lupus ErythematosusUnited States · Belgium · Bulgaria - Active not recruitingPHASE3
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
This study investigates a new medicine, obexelimab, for Warm Autoimmune Hemolytic Anemia (wAIHA). It aims to see how well it works and if it's safe for people who haven't responded to previous treatments.
For: Warm Autoimmune Hemolytic AnemiaItaly · Poland · Spain